Interius BioTherapeutics
Philadelphia, PA
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.
interiusbio.comCompany Details
Founded
- 2019
Employees
- Between 20 - 100 employees
Raised
- $154,383,872
Headquarters Location
- Philadelphia, PA
Public
- No
Acquired
- Yes
CEO
Philip R. Johnson
Founders
- Bruce PeacockSaar Gill
Company Collections
These are collections Interius BioTherapeutics is a part of. Click on the collection name to view similar companies.
Interius BioTherapeutics' Industries
Interius BioTherapeutics Headquarters Location
3401 Grays Ferry Suite 300, Philadelphia, PA 19146
Total Amount Raised: $154,383,872
Interius BioTherapeutics Funding Rounds
Series B
$51,432,536
Debt Financing
$21,451,331
Series A
$76,000,000
Series A Investors
Cormorant Asset ManagementFairmount Funds ManagementLongwood FundTellus BioVenturesBain Capital Life SciencesKnollwood Investment AdvisoryPfizer Venture InvestmentsLogos CapitalRA Capital ManagementOsage University Partners IIBrightEdge FundQuan CapitalThe Mark Foundation for Cancer ResearchAgent CapitalPenn Medicine Co-Investment ProgramUniversity of Pennsylvania (Penn)Seed
$5,500,000
Seed Investors
Tellus BioVenturesPenn Medicine Co-Investment ProgramAgent CapitalBruce A. PeacockThe Mark Foundation for Cancer Research
Funding info provided by Diffbot.
Interius BioTherapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Interius BioTherapeutics.